Remove 2006 Remove Drug Pricing Remove Labelling
article thumbnail

Four Crucial Questions about the Humira Biosimilar Price War (rerun)

Drug Channels

CVS Health launched Cordavis, a new subsidiary that will market a private label, low-list-price version of Sandoz’ Hyrimoz. Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies. d/b/a Drug Channels Institute.

article thumbnail

Drug Channels Outlook 2025 (NEW Live Video Webinar)

Drug Channels

Read on for full details on pricing and registration. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Fein will clearly distinguish his opinions and interpretations from the objective facts and data. He will draw from exclusive information found in DCI's economic reports.